KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 80 filers reported holding KEROS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $941,000 | -50.4% | 34,074 | -2.3% | 0.01% | -12.5% |
| Q1 2022 | $1,896,000 | -28.2% | 34,863 | -23.1% | 0.02% | -30.4% |
| Q4 2021 | $2,639,000 | +46.3% | 45,363 | 0.0% | 0.02% | +76.9% |
| Q3 2021 | $1,804,000 | +88.5% | 45,363 | +101.5% | 0.01% | +85.7% |
| Q2 2021 | $957,000 | -31.0% | 22,516 | 0.0% | 0.01% | -50.0% |
| Q1 2021 | $1,386,000 | -12.8% | 22,516 | 0.0% | 0.01% | -56.2% |
| Q4 2020 | $1,589,000 | +61.3% | 22,516 | -11.9% | 0.03% | +39.1% |
| Q3 2020 | $985,000 | – | 25,546 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,382,641 | $85,102,000 | 10.19% |
| Consonance Capital Management LP | 890,209 | $54,792,000 | 5.84% |
| CHI Advisors LLC | 400,468 | $24,649,000 | 4.94% |
| Fairmount Funds Management LLC | 109,333 | $6,729,000 | 2.84% |
| VR Adviser, LLC | 372,306 | $22,915,000 | 2.49% |
| Opaleye Management Inc. | 157,500 | $9,694,000 | 1.42% |
| Darwin Global Management, Ltd. | 86,887 | $5,348,000 | 1.05% |
| Orbimed Advisors | 1,679,417 | $103,368,000 | 0.97% |
| Nantahala Capital Management | 460,372 | $28,336,000 | 0.83% |
| Eventide Asset Management | 427,414 | $26,307,000 | 0.39% |